Increasing Adoption of Electroceuticals for Treatment of Various Neurological Disorders is Expected to Drive Electroceuticals/Bioelectric Medicine Market Revenue Growth

The global electroceuticals/bioelectric medicine market size is expected to reach USD 26.29 Billion in 2030 and register a revenue CAGR of 5.1% over the forecast period, according to latest report by Reports and Data. Increasing prevalence of chronic diseases and technological advancements in the electroceutical field are driving electroceuticals/bioelectric medicine market revenue growth.

Access Free sample PDF Copy of the Report @ 

Electroceutical devices or bioelectric medicine are being widely used in the treatment of several neurological disorders, such as Parkinson’s disease, Obsessive Compulsive Disorder (OCD), epilepsy, Alzheimer’s disease, dystonia, and essential tremor. It is effective in diagnosis and treatment of all disorders related to central and peripheral nervous systems, along with their subdivisions that include autonomic and somatic nervous systems.

Technological advancement has resulted in development of miniaturized electroceutical devices that can fit into nerve bundles within the human body. Electroceutical therapy can minimize the symptoms of a disease by targeting the neural circuitry and providing neural stimulation to specific targets, and these neural stimulations or impulses can be monitored by implantable devices. For instance, electroconvulsive therapy is widely used in the treatment of major depressive disorder, and in this procedure, electroceutical devices provide controlled electrical stimulation to trigger a brief seizure, which  affects chemicals and neurons in the brain.

Some Key Highlights from the Report

    • In January 2021, Boston Scientific Corporation, a U.S.-based manufacturer of medical devices, received authorization from the U.S. Food and Drug Administration (FDA) for its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. These devices are Bluetooth-enabled and are rechargeable or non-rechargeable based on doctor and patient preference. These would help to treat Parkinson’s disease by providing electrical impulses through surgically implanted leads in the brain, which are connected to Implantable Pulse Generator (IPG).
    • Cardiac pacemakers segment revenue is expected to grow at a steady rate during the forecast period. Cardiac pacemakers have the ability to regulate heartbeats in conditions where natural system of the heart cannot do it, and it also improves heart’s efficiency by ensuring the atria and ventricle work together. In addition, it helps in detection and rectification of the causes of atrial fibrillation or irregular heartbeat. Cardiac pacemakers can also help in preventing heart failure by ensuring proper functioning of the heart’s electrical system.
    • Implantable electroceutical segment accounted for largest revenue share in 2020, owing to their increasing adoption due to several benefits, such as compact & small design of devices, biodegradability, functionality of devices, and conformability. Wearable and Implantable Electroceuticals (WIEs) are widely being used in several applications, including muscle activation, heart stimulation, skin rejuvenation, and nerve modulation, and these devices accommodate several other therapeutic modalities as well. WIEs are mainly designed to activate the vagus nerve to improve heartbeat and breathing, and they are widely being used in the treatment of cardiac failure and epilepsy. For instance, NeuroPace Responsive Neural Stimulation (RNS) system is used to treat intractable epilepsy, while artificial pacemaker is the most widely used implantable electroceutical device for treating heart failure.
    • Parkinson’s disease segment accounted for a significantly large revenue share in 2020, which can be attributed to increasing use of Deep Brain Stimulation (DBS) for treating Parkinson’s disease. In treating Parkinson’s disease, DBS supplies electrical impulses to the particular area of the brain, which is accountable for motor symptoms generated by the disease. Electrical impulses interrupt abnormal activity in the brain circuitry and thus, minimizes symptoms of the condition.
    • Hospital segment accounted for a significantly large revenue share in 2020, which can be attributed to increasing pressure on these facilities due to growing incidence of several chronic diseases, such as epilepsy, retinitis pigmentosa, and arrhythmia. Electroceuticals/bioelectric devices are effective in minimizing severity of these diseases, which is increasing demand for these devices in hospitals.
    • Market in North America accounted for largest revenue share in 2020. Increase in geriatric population, coupled with rising use of retinal implants, are accelerating electroceuticals/bioelectric medicine market growth in the region. Additionally, presence of a highly developed healthcare sector and easy accessibility to advanced products are facilitating market revenue growth in the region. Presence of leading medical device manufacturers, such as Biotronic and Boston Scientific Corporation, is also contributing to market revenue growth.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Top Companies Profiled in the Report:

Boston Scientific Corporation, Abbott, Cochlear, Biotronik, LivaNova, PLC, electroCore, Inc., Sonova, Neuronetics, MicroPort Scientific Corporation, and NeuroPace, Inc.

To know more about the report, visit @ 

Electroceuticals/Bioelectric Medicine Market Segmentation:

Product Type Outlook (Revenue, USD Billion; 2018–2030)

  • Cardiac Pacemakers
  • Implantable Cardioverter Defibrillators
  • Stimulators
    • Spinal Cord
    • Deep Brain
    • Vagus Nerve
    • Sacral Nerve
  • Implants
    • Retinal
    • Cochlear
  • Transcutaneous Electrical Nerve Stimulation
  • Others

Device Type Outlook (Revenue, USD Billion; 2018–2030)

  • Implantable Electroceutical
  • Non-invasive Electroceutical

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Ask for Customize Research Report @ 

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore Latest Trending Research Reports By Reports and Data:

Antiseptics and Disinfectants Market Size, Share & Analysis, By Type (Chlorine Compounds, Quaternary Ammonium Compounds, Enzymes), By Product Type (Medical Device Disinfectants, Enzymatic Cleaners, Surface Disinfectants), By End-Use (Hospitals, Clinics), and By Region, Forecast To 2028

DNA Sequencing Market Size, Share, and Industry Analysis By Product & Services (Consumables, Instruments, Services), By Technology (Sanger Sequencing, Next-Generation Sequencing, Third Generation DNA Sequencing, By Application, End-Use, and By Region Forecast to 2028

Biomarkers Market By Product (Consumables, Software, Services), By Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers, Others), By Application (Drug Discovery and Development, Diagnostic, Disease Risk Assessment, Personalized Medicine, Others), By Disease Indication, And By Region Forecast To 2028

Cancer Diagnostics Market Size, Share & Analysis, By Test Type (Imaging, Laboratory Test, Genetic Test, Biopsy, Endoscopy, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Ovarian Cancer, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Research Institutes, Others), And Region, Segment Forecasts To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs



Back to news